Test Bank for Rau’s Respiratory Care Pharmacology, 9th Edition By Gardenhire

TEST BANK ,y,y




RAU’s Respiratory Care Pharmacology
,y,y ,y,y ,y,y




9TH EDITION ,y,y




BY GARDENHIRE
,y,y




TEST BANK ,y

,Description
Test Bank for Rau’s Respiratory Care Pharmacology 9th Edition Gardenhire
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




Test Bank for Rau’s Respiratory Care Pharmacology, 9th Edition, Gardenhire, ISBN-10:
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



0323299687, ISBN-13: 9780323299688
,y,y ,y,y ,y,y




Table of Contents ,y,y ,y,y




Unit I: Basic Concepts and Principles in Pharmacology
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




1. ,y,y Introduction to Respiratory Care Pharmacology ,y,y ,y,y ,y,y ,y,y



2. ,y,y Principles of Drug Action ,y,y ,y,y ,y,y



3. ,y,y Administration of Aerosolized Agents ,y,y ,y,y ,y,y



4. ,y,y Calculating Drug Doses ,y,y ,y,y



5. ,y,y The Central and Peripheral Nervous Systems
,y,y ,y,y ,y,y ,y,y ,y,y




Unit II: Drugs Used to Treat the Respiratory System
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




6. Adrenergic (Sympathomimetic) Bronchodilators
,y,y ,y,y ,y,y



7. Anticholinergic (Parasympatholytic) Bronchodilators
,y,y ,y,y ,y,y



8. Xanthines
,y,y



9. Mucus-Controlling Drug Therapy
,y,y ,y,y ,y,y



10. Surfactant Agents
,y,y ,y,y



11. Corticosteriods in Respiratory Care
,y,y ,y,y ,y,y ,y,y



12. Nonsteroidal Antiasthma Agents
,y,y ,y,y ,y,y



13. Aerosolized Antiinfective Agents
,y,y ,y,y ,y,y



14. Antimicrobial Agents
,y,y ,y,y



15. Cold and Cough Agents
,y,y ,y,y ,y,y ,y,y



16. Selected Agents of Pulmonary Value
,y,y ,y,y ,y,y ,y,y ,y,y



17. Neonatal and Pediatric Aerosolized Drug Therapy
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




Unit III: Critical Care, Cardiovascular, and Polysomnography Agents
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




18. ,y,y Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
,y,y ,y,y ,y,y ,y,y ,y,y



19. ,y,y Diuretic Agents ,y,y



20. ,y,y Drugs Affecting the Central Nervous System
,y,y ,y,y ,y,y ,y,y ,y,y



21. ,y,y Vasopressors, Inotropes, and Antiarrythmic Agents ,y,y ,y,y ,y,y ,y,y



22. ,y,y Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics
,y,y ,y,y ,y,y ,y,y ,y,y



23. ,y,y Sleep and Sleep Pharmacology ,y,y ,y,y ,y,y

,Chapter 01: Introduction to Respiratory Care Pharmacology
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




Gardenhire: Rau’s Respiratory Care Pharmacology, 9th Edition
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




MULTIPLE CHOICE ,y,y




1. What is the name of the receptor sites that are located in the peripheral vasculature, the heart,
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



bronchial muscle, and bronchial blood vessels?
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



a. Beta 2 receptors ,y,y c. Alpha receptors
,y,y ,y,y



b. Gamma receptors d. Beta 1 receptors
,y,y , y , y , y , y ,y,y ,y,y




ANS: C ,y,y



Alpha receptors are located in the peripheral vasculature, the heart, bronchial muscle, and
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




bronchial blood vessels.
,y,y ,y,y ,y,y




PTS: , y , y 1

2. Which receptor site results in tachycardia, an increased potential for arrhythmias, and an
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



increased cardiac output?
,y,y ,y,y ,y,y



a. Beta 1 receptor ,y,y c. Alpha receptor
,y,y ,y,y



b. Beta 2 receptor ,y,y d.
,y,y Delta receptor , y , y ,y,y




ANS: A ,y,y



Stimulation of the beta-1 receptors results in tachycardia, an increased potential for arrhythmias,
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




and an increased cardiac output. In administering drugs to the pulmonary system, stimulation of
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




the beta-1 sites is not desired. However, most respiratory pharmacologic agents have some
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




beta-1 stimulatory effect.
,y,y ,y,y ,y,y




PTS: , y , y 1

3. Stimulation of the beta 2 receptors causes ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



a. peripheral vasoconstriction and mild bronchoconstriction in the lungs.
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



b. tachycardia, an increased potential for arrhythmias, and an increased cardiac output.
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



c. bronchodilation.
d. peripheral vasodilation, bradycardia, and decreased cardiac output.
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




ANS: C ,y,y



Stimulation of the beta-2 receptors in the lungs causes bronchodilation.
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




PTS: , y , y 1

4. Acetylcholine stimulates ,y,y ,y,y



a. the Vagus nerve. ,y,y ,y,y



b. the adrenergic receptors.
,y,y ,y,y



c. the sympathetic nervous system.
,y,y ,y,y ,y,y



d. the cholinergic receptors.
,y,y ,y,y




ANS: D ,y,y



Acetylcholine stimulates the cholinergic receptors. ,y,y ,y,y ,y,y ,y,y




PTS: , y , y 1

5. What immunoglobulin antibody sensitizes the mast cell?
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



a. Leukotrienes c. Histamine

, b. IgE d. , y , y Prostaglandins
ANS: B ,y,y



The IgE (reagin) antibodies sensitize the mast cell. Repeated exposure to the antigen causes the
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



degranulation of the mast cell.
,y,y ,y,y ,y,y ,y,y ,y,y




PTS: , y , y 1

6. Which of the following is caused by histamine release from the mast cells?
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



I. Bronchodilation
II. Increased bronchial gland secretion ,y,y ,y,y ,y,y



III. Increased amount of mucus present in the airways ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



a. I and II only ,y,y c. III only
,y,y ,y,y ,y,y



b. II and III only ,y,y d. I, II, III
,y,y ,y,y , y , y , y , y ,y,y ,y,y




ANS: B ,y,y



Histamine is also a potent bronchoconstrictor. In addition to its bronchoconstrictive activity, histamine
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




II) increases bronchial gland secretion, causing III) an increase in the amount of mucus
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




present in the airways. Histamine may also have an effect on vascular permeability similar
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




to the effect of- SRS-A.
,y,y ,y,y ,y,y ,y,y ,y,y




PTS: , y , y 1

7. A sympathomimetic drug would cause
,y,y ,y,y ,y,y ,y,y ,y,y



a. bronchodilation. c. Histamine release. ,y,y



b. bronchoconstriction. d. Vagus nerve stimulation.
, y , y ,y,y ,y,y




ANS: A ,y,y



A sympathomimetic drug would cause bronchodilation. Sympathomimetic agents are the drugs most
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




commonly used to reverse bronchospasm.
,y,y ,y,y ,y,y ,y,y ,y,y




PTS: , y , y 1

8. Stimulation of the sympathetic nervous system causes ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



a. vascular permeability. c. bronchodilation. ,y,y



b. decreased blood pressure. d. bronchoconstriction. ,y,y ,y,y , y , y




ANS: C ,y,y



Sympathetic nervous system stimulation causes bronchodilation. ,y,y ,y,y ,y,y ,y,y ,y,y




PTS: , y , y 1

9. Which of the following would NOT cause a bronchospasm or bronchoconstriction?
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



a. Leukotrienes c. Histamine
b. Beta 1 receptors d. Prostaglandins
,y,y ,y,y , y , y




ANS: B ,y,y



Beta-1 receptors would not cause a bronchospasm or bronchoconstriction. Leukotrienes are one
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



of many chemical mediators released by the mast cells. Leukotrienes cause a direct, strong
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



bronchoconstriction. Histamine is also a potent bronchoconstrictor. Prostaglandins cause a
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y ,y,y



strong bronchospasm, especially in asthmatic patients.
,y,y ,y,y ,y,y ,y,y ,y,y ,y,y




PTS: , y , y 1